NYSEAMERICAN:CCEL Cryo-Cell International (CCEL) Stock Price, News & Analysis $3.99 -0.06 (-1.48%) Closing price 10/2/2026 04:10 PM EasternExtended Trading$3.98 -0.01 (-0.25%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Cryo-Cell International Stock (NYSEAMERICAN:CCEL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CCEL alerts:Sign Up Key Stats Today's Range$3.99▼$4.1150-Day Range$3.30▼$4.5652-Week Range$2.72▼$4.90Volume1,514 shsAverage Volume13,898 shsMarket Capitalization$32.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Cryo-Cell International, Inc. is a biotechnology and healthcare services company focused on the collection, processing, testing and long-term storage of umbilical cord blood and cord tissue. The company provides families with access to private stem cell banking services intended to preserve potentially valuable biological material for future medical use. Its services generally include coordinating the collection of cord blood and tissue at birth, transporting specimens to its processing facilities, isolating and cryopreserving stem cells, and maintaining the stored materials under controlled conditions. Cryo-Cell also offers related enrollment, storage-management and customer-support services for families that choose to bank their newborn’s cord-derived cells. Founded in 1989, Cryo-Cell is headquartered in Oldsmar, Florida. The company serves customers in the United States and has pursued international business through partnerships and distribution or licensing relationships. Its operations are centered on private cord blood and tissue banking rather than the development or sale of pharmaceutical products.AI Generated. May Contain Errors. Read More Cryo-Cell International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreCCEL MarketRank™: Cryo-Cell International scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingCryo-Cell International has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageCryo-Cell International has received no research coverage in the past 90 days.Read more about Cryo-Cell International's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryo-Cell International is -13.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryo-Cell International is -13.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.18% of the float of Cryo-Cell International has been sold short.Short Interest Ratio / Days to CoverCryo-Cell International has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cryo-Cell International has recently increased by 60.03%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCryo-Cell International does not currently pay a dividend.Dividend GrowthCryo-Cell International does not have a long track record of dividend growth. News and Social MediaN/ANews SentimentN/A Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cryo-Cell International insiders have not sold or bought any company stock.Percentage Held by Insiders38.59% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions10.44% of the stock of Cryo-Cell International is held by institutions.Read more about Cryo-Cell International's insider trading history. Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CCEL Stock News HeadlinesDer aktuelle Kurs der CryoCell International Inc Aktie beträgt 3,5700.August 6, 2026 | de.investing.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial ResultsJuly 15, 2026 | businesswire.comElon will prove them wrong againElon Musk's critics said self-driving cars were a pipe dream. Today, Tesla robotaxis carry passengers with no driver in major U.S. cities. Veteran tech investor James Altucher says Musk is applying the same playbook to a new project he calls his infinite money glitch, expected to launch October 21. Altucher, who has tracked tech breakthroughs for nearly four decades, calls this the biggest one he has ever covered.October 4 at 1:00 AM | Paradigm Press (Ad)Cryo-Cell Receives Acceptance of Compliance Plan From NYSE AmericanMay 8, 2026 | businesswire.comCryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood BanksApril 28, 2026 | finance.yahoo.comWall Street Analysts Are Neutral on Top Healthcare PicksApril 19, 2026 | theglobeandmail.comCryo-Cell International receives NYSE American notice over listing non-complianceMarch 13, 2026 | msn.comCryo-Cell Receives NYSE American Continued Listing NoticeMarch 12, 2026 | businesswire.comSee More Headlines CCEL Stock Analysis - Frequently Asked Questions How have CCEL shares performed this year? Cryo-Cell International's stock was trading at $3.44 on January 1st, 2026. Since then, CCEL stock has increased by 16.0% and is now trading at $3.99. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) posted its quarterly earnings results on Wednesday, July, 15th. The company reported $0.07 earnings per share for the quarter. The company earned $7.78 million during the quarter. How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Meta Platforms (META), Alimera Sciences (ALIM), Crescent Biopharma (CBIO), NVIDIA (NVDA), Aspen Group (ASPU). Company Calendar Last Earnings7/15/2026Today10/04/2026Fiscal Year End11/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CCEL's financial health is in the Green zone, according to TradeSmith. CCEL has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSEAMERICAN:CCEL CIK862692 Webwww.cryo-cell.com Phone(813) 749-2104Fax813-855-4745Employees76Year Founded1989Profitability EPS (Trailing Twelve Months)($1.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.43 million Net Margins-7.92% Pretax Margin-8.18% Return on EquityN/A Return on Assets-4.00% Debt Debt-to-Equity RatioN/A Current Ratio0.71 Quick Ratio0.69 Sales & Book Value Annual Sales$31.57 million Price / Sales1.02 Cash FlowN/A Price / Cash FlowN/A Book Value($2.31) per share Price / Book-1.73Miscellaneous Outstanding Shares8,060,000Free Float4,951,000Market Cap$32.16 million OptionableNot Optionable Beta0.50 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSEAMERICAN:CCEL) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...Stansberry Research | SponsoredFree Stock: Economist calls it “the world’s most important machine.”Nvidia's most expensive chip component isn't made by Nvidia. Jeff Brown, former semiconductor executive, says ...Brownstone Research | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryo-Cell International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CCEL Stock Alerts